Leutholtz B, Kreider RB: Exercise and Sport Nutrition. Nutritional Health. Edited by: Wilson T, Temple N. 2001, Totowa, NJ: Humana Press, Inc, 207–39.
Williams MH: Nutrition for Health, Fitness, and Sport. 1999, Dubuque, IA: ACB/McGraw-Hill
FDA: Dietary Supplements. 2003, [http://www.cfsan.fda.gov/~dms/ds-faq.html]
US RDA Recommendations. [http://www.lifestyler.com/jr/rdachart.htm]
Beers MH, Berkow R: The Merck Manual. 1999, Merck Research Laboratories, 17
PDR for Nutritional Supplements. 2001, Montvale, NJ.: Medical Economics Co
PDR for Herbal Medicines. 2000, Montvale, NJ.: Medical Economics Co, [http://physician.pdr.net/physician/static.htm?path=controlled/searchpdrherbal.htm]2
The Natural Health Encyclopedia. 2002, [http://www.tnp.com/encyclopedia/]
National Library of Medicine/Pub Med. 2002, [http://www.ncbi.nlm.nih.gov/PubMed/]
Sherman WM, Jacobs KA, Leenders N: Carbohydrate metabolism during endurance exercise. Overtraining in Sport. Edited by: Kreider RB, Fry AC, O'Toole ML. 1998, Champaign: Human Kinetics Publishers, 289–308.
Berning JR: Energy intake, diet, and muscle wasting. Overtraining in Sport. Edited by: Kreider RB, Fry AC, O'Toole ML. 1998, Champaign: Human Kinetics, 275–88.
Kreider RB, Fry AC, O'Toole ML: Overtraining in Sport. 1998, Champaign, IL.: Human Kinetics Publishers
Kreider RB: Physiological considerations of ultraendurance performance. Int J Sport Nutr. 1991, 1 (1): 3–27.
Brouns F, Saris WH, Beckers E: Metabolic changes induced by sustained exhaustive cycling and diet manipulation. Int J Sports Med. 1989, 10 (Suppl 1): S49–62. 10.1055/s-2007-1024954.
Brouns F, Saris WH, Stroecken J: Eating, drinking, and cycling. A controlled Tour de France simulation study, Part II. Effect of diet manipulation. Int J Sports Med. 1989, 10 (Suppl 1): S41–8. 10.1055/s-2007-1024953.
Lemon PW, Tarnopolsky MA, MacDougall JD, Atkinson SA: Protein requirements and muscle mass/strength changes during intensive training in novice bodybuilders. J Appl Physiol. 1992, 73 (2): 767–75.
Tarnopolsky MA, MacDougall JD, Atkinson SA: Influence of protein intake and training status on nitrogen balance and lean body mass. J Appl Physiol. 1988, 64 (1): 187–93.
Tarnopolsky MA, Atkinson SA, MacDougall JD, Chesley A, Phillips S, Schwarcz HP: Evaluation of protein requirements for trained strength athletes. J Appl Physiol. 1992, 73 (5): 1986–95.
Tarnopolsky MA: Protein and physical performance. Curr Opin Clin Nutr Metab Care. 1999, 2 (6): 533–7. 10.1097/00075197-199911000-00018.
Kreider RB: Effects of protein and amino acid supplementation on athletic performance. Sportscience. 1999, 3 (1): [http://www.sportsci.org/jour/9901/rbk.html]
Kreider RB, Kleiner SM: Protein supplements for athletes: need vs. convenience. Your Patient & Fitness. 2000, 14 (6): 12–8.
Bucci L, Unlu L: Proteins and amino acid supplements in exercise and sport. Energy-Yielding Macronutrients and Energy Metabolism in Sports Nutrition. Edited by: Driskell J, Wolinsky I. 2000, Boca Raton, FL: CRC Press, 191–212.
Boirie Y, Dangin M, Gachon P, Vasson MP, Maubois JL, Beaufrere B: Slow and fast dietary proteins differently modulate postprandial protein accretion. Proc Natl Acad Sci USA. 1997, 94 (26): 14930–5. 10.1073/pnas.94.26.14930.
Boirie Y, Gachon P, Cordat N, Ritz P, Beaufrere B: Differential insulin sensitivities of glucose, amino acid, and albumin metabolism in elderly men and women. J Clin Endocrinol Metab. 2001, 86 (2): 638–44. 10.1210/jc.86.2.638.
Boirie Y, Gachon P, Corny S, Fauquant J, Maubois JL, Beaufrere B: Acute postprandial changes in leucine metabolism as assessed with an intrinsically labeled milk protein. Am J Physiol. 1996, 271 (6 Pt 1): E1083–91.
Venkatraman JT, Leddy J, Pendergast D: Dietary fats and immune status in athletes: clinical implications. Med Sci Sports Exerc. 2000, 32 (7 Suppl): S389–95.
Dorgan JF, Judd JT, Longcope C: Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: a controlled feeding study. Am J Clin Nutr. 1996, 64 (6): 850–5.
Hamalainen EK, Adlercreutz H, Puska P, Pietinen P: Decrease of serum total and free testosterone during a low-fat high-fibre diet. J Steroid Biochem. 1983, 18 (3): 369–70. 10.1016/0022-4731(83)90117-6.
Reed MJ, Cheng RW, Simmonds M, Richmond W, James VH: Dietary lipids: an additional regulator of plasma levels of sex hormone binding globulin. J Clin Endocrinol Metab. 1987, 64 (5): 1083–5. 10.1210/jcem-64-5-1083.
Fry AC, Kraemer WJ, Ramsey LT: Pituitary-adrenal-gonadal responses to high-intensity resistance exercise overtraining. J Appl Physiol. 1998, 85 (6): 2352–9.
Miller WC, Koceja DM, Hamilton EJ: A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention. Int J Obes Relat Metab Disord. 1997, 21 (10): 941–7. 10.1038/sj.ijo.0800499.
Miller WC: Effective diet and exercise treatments for overweight and recommendations for intervention. Sports Med. 2001, 31 (10): 717–24. 10.2165/00007256-200131100-00002.
Pirozzo S, Summerbell C, Cameron C, Glasziou P: Should we recommend low-fat diets for obesity?. Obes Rev. 2003, 4 (2): 83–90. 10.1046/j.1467-789X.2003.00099.x.
Hu FB, Manson JE, Willett WC: Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr. 2001, 20 (1): 5–19.
Vessby B: Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol. 2003, 14 (1): 15–9. 10.1097/00041433-200302000-00004.
Kreider RB: Dietary supplements and the promotion of muscle growth with resistance exercise. Sports Med. 1999, 27 (2): 97–110. 10.2165/00007256-199927020-00003.
Kreider RB: Nutritional Considerations of Overtraining. Sport Supplements: A Complete Guide to Physique and Athletic Enhancement. Edited by: Stout JR, Antonio J. 2001, Baltimore, MD: Lippincott, Williams & Wilkins, 199–208.
Carli G, Bonifazi M, Lodi L, Lupo C, Martelli G, Viti A: Changes in the exercise-induced hormone response to branched chain amino acid administration. Eur J Appl Physiol Occup Physiol. 1992, 64 (3): 272–7. 10.1007/BF00626291.
Cade JR, Reese RH, Privette RM, Hommen NM, Rogers JL, Fregly MJ: Dietary intervention and training in swimmers. Eur J Appl Physiol Occup Physiol. 1991, 63 (3–4): 210–5. 10.1007/BF00233850.
Nieman DC, Fagoaga OR, Butterworth DE: Carbohydrate supplementation affects blood granulocyte and monocyte trafficking but not function after 2.5 h or running. Am J Clin Nutr. 1997, 66 (1): 153–9.
Nieman DC: Influence of carbohydrate on the immune response to intensive, prolonged exercise. Exerc Immunol Rev. 1998, 4: 64–76.
Nieman DC: Nutrition, exercise, and immune system function. Clin Sports Med. 1999, 18 (3): 537–48. 10.1016/S0278-5919(05)70167-8.
Burke LM: Nutritional needs for exercise in the heat. Comp Biochem Physiol A Mol Integr Physiol. 2001, 128 (4): 735–48. 10.1016/S1095-6433(01)00279-3.
Burke LM: Nutrition for post-exercise recovery. Aust J Sci Med Sport. 1997, 29 (1): 3–10.
Maughan RJ, Noakes TD: Fluid replacement and exercise stress. A brief review of studies on fluid replacement and some guidelines for the athlete. Sports Med. 1991, 12 (1): 16–31. 10.2165/00007256-199112010-00003.
Zawadzki KM, Yaspelkis BB, Ivy JL: Carbohydrate-protein complex increases the rate of muscle glycogen storage after exercise. J Appl Physiol. 1992, 72 (5): 1854–9.
Tarnopolsky MA, Bosman M, Macdonald JR, Vandeputte D, Martin J, Roy BD: Postexercise protein-carbohydrate and carbohydrate supplements increase muscle glycogen in men and women. J Appl Physiol. 1997, 83 (6): 1877–83.
Kraemer WJ, Volek JS, Bush JA, Putukian M, Sebastianelli WJ: Hormonal responses to consecutive days of heavy-resistance exercise with or without nutritional supplementation. J Appl Physiol. 1998, 85 (4): 1544–55.
Brouns F, Kovacs EM, Senden JM: The effect of different rehydration drinks on post-exercise electrolyte excretion in trained athletes. Int J Sports Med. 1998, 19 (1): 56–60. 10.1055/s-2007-971881.
Kovacs EM, Senden JM, Brouns F: Urine color, osmolality and specific electrical conductance are not accurate measures of hydration status during postexercise rehydration. J Sports Med Phys Fitness. 1999, 39 (1): 47–53.
Kovacs EM, Schmahl RM, Senden JM, Brouns F: Effect of high and low rates of fluid intake on post-exercise rehydration. Int J Sport Nutr Exerc Metab. 2002, 12 (1): 14–23.
Meyer LG, Horrigan DJ, Lotz WG: Effects of three hydration beverages on exercise performance during 60 hours of heat exposure. Aviat Space Environ Med. 1995, 66 (11): 1052–7.
Williams MH, Kreider R, Branch JD: Creatine: The power supplement. 1999, Champaign, IL: Human Kinetics Publishers
Kreider RB: Effects of creatine supplementation on performance and training adaptations. Mol Cell Biochem. 2003, 244 (1–2): 89–94. 10.1023/A:1022465203458.
Volek JS, Duncan ND, Mazzetti SA: Performance and muscle fiber adaptations to 12 weeks of creatine supplementation and heavy resistance training. Medicine & Science in Sports & Exercise. 1999, 31 (5):
Willoughby DS, Rosene J: Effects of oral creatine and resistance training on myosin heavy chain expression. Med Sci Sports Exerc. 2001, 33 (10): 1674–81. 10.1097/00005768-200110000-00010.
Willoughby DS, Rosene JM: Effects of oral creatine and resistance training on myogenic regulatory factor expression. Med Sci Sports Exerc. 2003, 35 (6): 923–9. 10.1249/01.MSS.0000069746.05241.F0.
Kreider RB, Melton C, Rasmussen CJ: Long-term creatine supplementation does not significantly affect clinical markers of health in athletes. Mol Cell Biochem. 2003, 244 (1–2): 95–104. 10.1023/A:1022469320296.
Graham AS, Hatton RC: Creatine: a review of efficacy and safety. J Am Pharm Assoc (Wash). 1999, 39 (6): 803–10.
Juhn MS, Tarnopolsky M: Potential side effects of oral creatine supplementation: a critical review. Clin J Sport Med. 1998, 8 (4): 298–304. 10.1097/00042752-199810000-00007.
Taes YE, Delanghe JR, Wuyts B, Van De Voorde J, Lameire NH: Creatine supplementation does not affect kidney function in an animal model with pre-existing renal failure. Nephrol Dial Transplant. 2003, 18 (2): 258–64. 10.1093/ndt/18.2.258.
Schilling BK, Stone MH, Utter A: Creatine supplementation and health variables: a retrospective study. Med Sci Sports Exerc. 2001, 33 (2): 183–8.
Greenwood M, Kreider RB, Melton C: Creatine supplementation during college football training does not increase the incidence of cramping or injury. Mol Cell Biochem. 2003, 244 (1–2): 83–8. 10.1023/A:1022413202549.
Greenwood M, Kreider R, Melton C: Creatine supplementation during college football training does not increase the incidence of cramping or injury. Mol Cell Biochem. 2002,
Watsford ML, Murphy AJ, Spinks WL, Walshe AD: Creatine supplementation and its effect on musculotendinous stiffness and performance. J Strength Cond Res. 2003, 17 (1): 26–33. 10.1519/1533-4287(2003)017<0026:CSAIEO>2.0.CO;2.
Nair KS, Matthews DE, Welle SL, Braiman T: Effect of leucine on amino acid and glucose metabolism in humans. Metabolism. 1992, 41 (6): 643–8. 10.1016/0026-0495(92)90057-H.
Gallagher PM, Carrithers JA, Godard MP, Schulze KE, Trappe SW: Beta-hydroxy-beta-methylbutyrate ingestion, Part I: effects on strength and fat free mass. Med Sci Sports Exerc. 2000, 32 (12): 2109–15. 10.1097/00005768-200012000-00022.
Gallagher PM, Carrithers JA, Godard MP, Schulze KE, Trappe SW: Beta-hydroxy-beta-methylbutyrate ingestion, part II: effects on hematology, hepatic and renal function. Med Sci Sports Exerc. 2000, 32 (12): 2116–9. 10.1097/00005768-200012000-00023.
Nissen S, Sharp R, Ray M: Effect of leucine metabolite beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistance-exercise training. J Appl Physiol. 1996, 81 (5): 2095–104.
Panton LB, Rathmacher JA, Baier S, Nissen S: Nutritional supplementation of the leucine metabolite beta-hydroxy-beta-methylbutyrate (hmb) during resistance training. Nutrition. 2000, 16 (9): 734–9. 10.1016/S0899-9007(00)00376-2.
Slater GJ, Jenkins D: Beta-hydroxy-beta-methylbutyrate (HMB) supplementation and the promotion of muscle growth and strength. Sports Med. 2000, 30 (2): 105–16. 10.2165/00007256-200030020-00004.
Nissen S, Sharp RL, Panton L, Vukovich M, Trappe S, Fuller JC: beta-hydroxy-beta-methylbutyrate (HMB) supplementation in humans is safe and may decrease cardiovascular risk factors. J Nutr. 2000, 130 (8): 1937–45.
Vukovich MD, Stubbs NB, Bohlken RM: Body composition in 70-year-old adults responds to dietary beta-hydroxy-beta-methylbutyrate similarly to that of young adults. J Nutr. 2001, 131 (7): 2049–52.
Knitter AE, Panton L, Rathmacher JA, Petersen A, Sharp R: Effects of beta-hydroxy-beta-methylbutyrate on muscle damage after a prolonged run. J Appl Physiol. 2000, 89 (4): 1340–4.
Jowko E, Ostaszewski P, Jank M: Creatine and beta-hydroxy-beta-methylbutyrate (HMB) additively increase lean body mass and muscle strength during a weight-training program. Nutrition. 2001, 17 (7–8): 558–66. 10.1016/S0899-9007(01)00540-8.
O'Connor DM, Crowe MJ: Effects of beta-hydroxy-beta-methylbutyrate and creatine monohydrate supplementation on the aerobic and anaerobic capacity of highly trained athletes. J Sports Med Phys Fitness. 2003, 43 (1): 64–8.
Kreider RB, Ferreira M, Wilson M, Almada AL: Effects of calcium beta-hydroxy-beta-methylbutyrate (HMB) supplementation during resistance-training on markers of catabolism, body composition and strength. Int J Sports Med. 1999, 20 (8): 503–9. 10.1055/s-1999-8835.
Slater G, Jenkins D, Logan P: Beta-hydroxy-beta-methylbutyrate (HMB) supplementation does not affect changes in strength or body composition during resistance training in trained men. Int J Sport Nutr Exerc Metab. 2001, 11 (3): 384–96.
Ransone J, Neighbors K, Lefavi R, Chromiak J: The effect of beta-hydroxy beta-methylbutyrate on muscular strength and body composition in collegiate football players. J Strength Cond Res. 2003, 17 (1): 34–9. 10.1519/1533-4287(2003)017<0034:TEOHMO>2.0.CO;2.
Coombes JS, McNaughton LR: Effects of branched-chain amino acid supplementation on serum creatine kinase and lactate dehydrogenase after prolonged exercise. J Sports Med Phys Fitness. 2000, 40 (3): 240–6.
Schena F, Guerrini F, Tregnaghi P, Kayser B: Branched-chain amino acid supplementation during trekking at high altitude. The effects on loss of body mass, body composition, and muscle power. Eur J Appl Physiol Occup Physiol. 1992, 65 (5): 394–8. 10.1007/BF00243503.
Bigard AX, Lavier P, Ullmann L, Legrand H, Douce P, Guezennec CY: Branched-chain amino acid supplementation during repeated prolonged skiing exercises at altitude. Int J Sport Nutr. 1996, 6 (3): 295–306.
Candeloro N, Bertini I, Melchiorri G, De Lorenzo A: [Effects of prolonged administration of branched-chain amino acids on body composition and physical fitness]. Minerva Endocrinol. 1995, 20 (4): 217–23.
Tipton KD, Borsheim E, Wolf SE, Sanford AP, Wolfe RR: Acute response of net muscle protein balance reflects 24-h balance after exercise and amino acid ingestion. Am J Physiol Endocrinol Metab. 2003, 284 (1): E76–89.
Wolfe RR: Regulation of muscle protein by amino acids. J Nutr. 2002, 132 (10): 3219S–24S.
Rasmussen BB, Tipton KD, Miller SL, Wolf SE, Wolfe RR: An oral essential amino acid-carbohydrate supplement enhances muscle protein anabolism after resistance exercise. J Appl Physiol. 2000, 88 (2): 386–92.
Tipton KD, Rasmussen BB, Miller SL: Timing of amino acid-carbohydrate ingestion alters anabolic response of muscle to resistance exercise. Am J Physiol Endocrinol Metab. 2001, 281 (2): E197–206.
Rasmussen BB, Wolfe RR, Volpi E: Oral and intravenously administered amino acids produce similar effects on muscle protein synthesis in the elderly. J Nutr Health Aging. 2002, 6 (6): 358–62.
Miller SL, Tipton KD, Chinkes DL, Wolf SE, Wolfe RR: Independent and combined effects of amino acids and glucose after resistance exercise. Med Sci Sports Exerc. 2003, 35 (3): 449–55. 10.1249/01.MSS.0000053910.63105.45.
Kobayashi H, Borsheim E, Anthony TG: Reduced amino acid availability inhibits muscle protein synthesis and decreases activity of initiation factor eIF2B. Am J Physiol Endocrinol Metab. 2003, 284 (3): E488–98.
Borsheim E, Tipton KD, Wolf SE, Wolfe RR: Essential amino acids and muscle protein recovery from resistance exercise. Am J Physiol Endocrinol Metab. 2002, 283 (4): E648–57.
Biolo G, Williams BD, Fleming RY, Wolfe RR: Insulin action on muscle protein kinetics and amino acid transport during recovery after resistance exercise. Diabetes. 1999, 48 (5): 949–57. 10.2337/diabetes.48.5.949.
Esmarck B, Andersen JL, Olsen S, Richter EA, Mizuno M, Kjaer M: Timing of postexercise protein intake is important for muscle hypertrophy with resistance training in elderly humans. J Physiol. 2001, 535 (Pt 1): 301–11. 10.1111/j.1469-7793.2001.00301.x.
Low SY, Taylor PM, Rennie MJ: Responses of glutamine transport in cultured rat skeletal muscle to osmotically induced changes in cell volume. J Physiol. 1996, 492 (Pt 3): 877–85.
Rennie MJ, Khogali SE, Low SY: Amino acid transport in heart and skeletal muscle and the functional consequences. Biochem Soc Trans. 1996, 24 (3): 869–73.
Rennie MJ, Ahmed A, Khogali SE, Low SY, Hundal HS, Taylor PM: Glutamine metabolism and transport in skeletal muscle and heart and their clinical relevance. J Nutr. 1996, 126 (4 Suppl): 1142S–9S.
Varnier M, Leese GP, Thompson J, Rennie MJ: Stimulatory effect of glutamine on glycogen accumulation in human skeletal muscle. Am J Physiol. 1995, 269 (2 Pt 1): E309–15.
Antonio J, Street C: Glutamine: a potentially useful supplement for athletes. Can J Appl Physiol. 1999, 24 (1): 1–14.
Colker CM: Effects of supplemental protein on body composition and muscular strength in healthy athletic male adults. Curr Ther Res. 2000, 61 (1): 19–28. 10.1016/S0011-393X(00)88492-1.
Wernerman J, Hammarqvist F, Vinnars E: Alpha-ketoglutarate and postoperative muscle catabolism. Lancet. 1990, 335 (8691): 701–3. 10.1016/0140-6736(90)90811-I.
Hammarqvist F, Wernerman J, von der Decken A, Vinnars E: Alanyl-glutamine counteracts the depletion of free glutamine and the postoperative decline in protein synthesis in skeletal muscle. Ann Surg. 1990, 212 (5): 637–44. 10.1097/00000658-199011000-00012.
Antonio J, Stout JR: Sport Supplements. 2001, Philadelphia, PA: Lippincott, Williams and Wilkins
Mitch WE, Walser M, Sapir DG: Nitrogen sparing induced by leucine compared with that induced by its keto analogue, alpha-ketoisocaproate, in fasting obese man. J Clin Invest. 1981, 67 (2): 553–62. 10.1172/JCI110066.
Van Koevering M, Nissen S: Oxidation of leucine and alpha-ketoisocaproate to beta-hydroxy-beta-methylbutyrate in vivo. Am J Physiol. 1992, 262 (1 Pt 1): E27–31.
Slama K, Koudela K, Tenora J, Mathova A: Insect hormones in vertebrates: anabolic effects of 20-hydroxyecdysone in Japanese quail. Experientia. 1996, 52 (7): 702–6. 10.1007/BF01925578.
Slama K, Kodkoua M: Insect hormones and bioanalogues: their effect on respiratory metabolism in Dermestes vulpinus L. (Coleoptera). Biol Bull. 1975, 148 (2): 320–32. 10.2307/1540550.
Tashmukhamedova MA, Almatov KT, Syrov VN, Sultanov MB, Abidov AA: [Effect of phytoecdisteroids and anabolic steroids on liver mitochondrial respiration and oxidative phosphorylation in alloxan diabetic rats]. Nauchnye Doki Vyss Shkoly Biol Nauki. 1985, 37–9. 9
Syrov VN: [Mechanism of the anabolic action of phytoecdisteroids in mammals]. Nauchnye Doki Vyss ShkolyBiol Nauki. 1984, 16–20. 11
Kholodova Y: Phytoecdysteroids: biological effects, application in agriculture and complementary medicine (as presented at the 14-th Ecdysone Workshop, July, Rapperswil, Switzerland). Ukr Biokhim Zh. 2000, 73 (3): 21–9.
Bowers CY: Growth hormone-releasing peptide (GHRP). Cell Mol Life Sci. 1998, 54 (12): 1316–29. 10.1007/s000180050257.
Camanni F, Ghigo E, Arvat E: Growth hormone-releasing peptides and their analogs. Front Neuroendocrinol. 1998, 19 (1): 47–72. 10.1006/frne.1997.0158.
Messina M, Messina V: Soyfoods, soybean isoflavones, and bone health: a brief overview. J Ren Nutr. 2000, 10 (2): 63–8. 10.1016/S1051-2276(00)90001-3.
Messina M: Soyfoods and soybean phyto-oestrogens (isoflavones) as possible alternatives to hormone replacement therapy (HRT). Eur J Cancer. 2000, 36 (Suppl 4): S71–2. 10.1016/S0959-8049(00)00233-1.
de Aloysio D, Gambacciani M, Altieri P: Bone density changes in postmenopausal women with the administration of ipriflavone alone or in association with low-dose ERT. Gynecol Endocrinol. 1997, 11 (4): 289–93. 10.3109/09513599709152548.
US Patent 3949085: Anabolic-weight-gain promoting compositions containing isoflavone derivatives and method using same. [http://www.delphion.com/details?pn=US03949085]
US Patent 4163746: Metabolic 5-methyl-isoflavone-derivatives, process for the preparation thereof and compositions containing the same. [http://www.delphion.com/details?&pn=US04163746]
Chetlin RD, Yeater RA, Ullrich IH, Hornsby WG, Malanga CJ, Byrner RW: The effect of ornithine alpha-ketoglutarate (OKG) on healthy, weight trained men. J Exerc Physiol Online. 2000, 3 (4): [http://www.css.edu/users/tboone2/asep/ChetlinV.pdf]
Gonzalez-Cadavid NF, Taylor WE, Yarasheski K: Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci USA. 1998, 95 (25): 14938–43. 10.1073/pnas.95.25.14938.
McPherron AC, Lee SJ: Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA. 1997, 94 (23): 12457–61. 10.1073/pnas.94.23.12457.
McPherron AC, Lawler AM, Lee SJ: Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997, 387 (6628): 83–90. 10.1038/387083a0.
Grobet L, Martin LJ, Poncelet D: A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet. 1997, 17 (1): 71–4. 10.1038/ng0997-71.
Kambadur R, Sharma M, Smith TP, Bass JJ: Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res. 1997, 7 (9): 910–6.
Ivey FM, Roth SM, Ferrell RE: Effects of age, gender, and myostatin genotype on the hypertrophic response to heavy resistance strength training. J Gerontol A Biol Sci Med Sci. 2000, 55 (11): M641–8.
Carlson CJ, Booth FW, Gordon SE: Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol. 1999, 277 (2 Pt 2): R601–6.
Brilla LR, Conte V: Effects of a novel zing-magnesium formulation on hormones and strength. J Exerc Physiol Online. 2000, 3 (4): [http://www.css.edu/users/tboone2/asep/BrillaV.pdf]
Green NR, Ferrando AA: Plasma boron and the effects of boron supplementation in males. Environ Health Perspect. 1994, 102 (Suppl 7): 73–7. 10.2307/3431966.
Ferrando AA, Green NR: The effect of boron supplementation on lean body mass, plasma testosterone levels, and strength in male bodybuilders. Int J Sport Nutr. 1993, 3 (2): 140–9.
Evans GW: The effect of chromium picolinate on insulin controlled parameters in humans. Int Biosc Med Res. 1989, 11: 163–80.
Hasten DL, Rome EP, Franks BD, Hegsted M: Effects of chromium picolinate on beginning weight training students. Int J Sport Nutr. 1992, 2 (4): 343–50.
Grant KE, Chandler RM, Castle AL, Ivy JL: Chromium and exercise training: effect on obese women. Med Sci Sports Exerc. 1997, 29 (8): 992–8.
Campbell WW, Joseph LJ, Davey SL, Cyr-Campbell D, Anderson RA, Evans WJ: Effects of resistance training and chromium picolinate on body composition and skeletal muscle in older men. J Appl Physiol. 1999, 86 (1): 29–39.
Walker LS, Bemben MG, Bemben DA, Knehans AW: Chromium picolinate effects on body composition and muscular performance in wrestlers. Med Sci Sports Exerc. 1998, 30 (12): 1730–7. 10.1097/00005768-199812000-00012.
Livolsi JM, Adams GM, Laguna PL: The effect of chromium picolinate on muscular strength and body composition in women athletes. J Strength Cond Res. 2001, 15 (2): 161–6. 10.1519/1533-4287(2001)015<0161:TEOCPO>2.0.CO;2.
Volpe SL, Huang HW, Larpadisorn K, Lesser II: Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program. J Am Coll Nutr. 2001, 20 (4): 293–306.
Hallmark MA, Reynolds TH, DeSouza CA, Dotson CO, Anderson RA, Rogers MA: Effects of chromium and resistive training on muscle strength and body composition. Med Sci Sports Exerc. 1996, 28 (1): 139–44. 10.1097/00005768-199601000-00025.
Lukaski HC, Bolonchuk WW, Siders WA, Milne DB: Chromium supplementation and resistance training: effects on body composition, strength, and trace element status of men. Am J Clin Nutr. 1996, 63 (6): 954–65.
Clancy SP, Clarkson PM, DeCheke ME: Effects of chromium picolinate supplementation on body composition, strength, and urinary chromium loss in football players. Int J Sport Nutr. 1994, 4 (2): 142–53.
Pariza MW, Park Y, Cook ME: Conjugated linoleic acid and the control of cancer and obesity. Toxicol Sci. 1999, 52 (2 Suppl): 107–10.
Pariza MW, Park Y, Cook ME: Mechanisms of action of conjugated linoleic acid: evidence and speculation. Proc Soc Exp Biol Med. 2000, 223 (1): 8–13. 10.1046/j.1525-1373.2000.22302.x.
Pariza MW, Park Y, Cook ME: The biologically active isomers of conjugated linoleic acid. Prog Lipid Res. 2001, 40 (4): 283–98. 10.1016/S0163-7827(01)00008-X.
DeLany JP, Blohm F, Truett AA, Scimeca JA, West DB: Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am J Physiol. 1999, 276 (4 Pt 2): R1172–9.
DeLany JP, West DB: Changes in body composition with conjugated linoleic acid. J Am Coll Nutr. 2000, 19 (4): 487S–93S.
Park Y, Albright KJ, Liu W, Storkson JM, Cook ME, Pariza MW: Effect of conjugated linoleic acid on body composition in mice. Lipids. 1997, 32 (8): 853–8. 10.1007/s11745-997-0109-x.
Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O: Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr. 2000, 130 (12): 2943–8.
Gaullier JM, Berven G, Blankson H, Gudmundsen O: Clinical trial results support a preference for using CLA preparations enriched with two isomers rather than four isomers in human studies. Lipids. 2002, 37 (11): 1019–25. 10.1007/s11745-002-0995-y.
Zambell KL, Keim NL, Van Loan MD: Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids. 2000, 35 (7): 777–82. 10.1007/s11745-000-0585-z.
Kreider RB, Ferreira MP, Greenwood M, Wilson M, Almada AL: Effects of conjugated linoleic acid supplementation during resistance training on body composition, bone density, strength, and selected hematological markers. J Strength Cond Res. 2002, 16 (3): 325–34. 10.1519/1533-4287(2002)016<0325:EOCLAS>2.0.CO;2.
Wheeler KB, Garleb KA: Gamma oryzanol-plant sterol supplementation: metabolic, endocrine, and physiologic effects. Int J Sport Nutr. 1991, 1 (2): 170–7.
Fry AC, Bonner E, Lewis DL, Johnson RL, Stone MH, Kraemer WJ: The effects of gamma-oryzanol supplementation during resistance exercise training. Int J Sport Nutr. 1997, 7 (4): 318–29.
Yarasheski KE: Growth hormone effects on metabolism, body composition, muscle mass, and strength. Exerc Sport Sci Rev. 1994, 22: 285–312. 10.1249/00003677-199401000-00013.
Lukas SE: Current perspectives on anabolic-androgenic steroid abuse. Trends Pharmacol Sci. 1993, 14 (2): 61–8. 10.1016/0165-6147(93)90032-F.
Wagner JC: Enhancement of athletic performance with drugs. An overview. Sports Med. 1991, 12 (4): 250–65. 10.2165/00007256-199112040-00004.
Limbird TJ: Anabolic steroids in the training and treatment of athletes. Compr Ther. 1985, 11 (1): 25–30.
Kuhn CM: Anabolic steroids. Recent Prog Horm Res. 2002, 57: 411–34. 10.1210/rp.57.1.411.
Smart T: Other therapies for wasting. GMHC Treat Issues. 1995, 9 (5): 7–8.
Casaburi R: Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Med Sci Sports Exerc. 2001, 33 (7 Suppl): S662–70.
Hayes VY, Urban RJ, Jiang J, Marcell TJ, Helgeson K, Mauras N: Recombinant human growth hormone and recombinant human insulin-like growth factor I diminish the catabolic effects of hypogonadism in man: metabolic and molecular effects. J Clin Endocrinol Metab. 2001, 86 (5): 2211–9. 10.1210/jc.86.5.2211.
Newshan G, Leon W: The use of anabolic agents in HIV disease. Int J STD AIDS. 2001, 12 (3): 141–4. 10.1258/0956462011916893.
Tenover JS: Androgen replacement therapy to reverse and/or prevent age-associated sarcopenia in men. Baillieres Clin Endocrinol Metab. 1998, 12 (3): 419–25. 10.1016/S0950-351X(98)80153-5.
Bross R, Casaburi R, Storer TW, Bhasin S: Androgen effects on body composition and muscle function: implications for the use of androgens as anabolic agents in sarcopenic states. Baillieres Clin Endocrinol Metab. 1998, 12 (3): 365–78. 10.1016/S0950-351X(98)80077-3.
Casaburi R: Rationale for anabolic therapy to facilitate rehabilitation in chronic obstructive pulmonary disease. Baillieres Clin Endocrinol Metab. 1998, 12 (3): 407–18. 10.1016/S0950-351X(98)80134-1.
Johansen KL, Mulligan K, Schambelan M: Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. Jama. 1999, 281 (14): 1275–81. 10.1001/jama.281.14.1275.
Sattler FR, Jaque SV, Schroeder ET: Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus. J Clin Endocrinol Metab. 1999, 84 (4): 1268–76. 10.1210/jc.84.4.1268.
Beiner JM, Jokl P, Cholewicki J, Panjabi MM: The effect of anabolic steroids and corticosteroids on healing of muscle contusion injury. Am J Sports Med. 1999, 27 (1): 2–9.
Ferreira IM, Verreschi IT, Nery LE: The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest. 1998, 114 (1): 19–28. 10.1378/chest.114.1.19.
Bhasin S, Storer TW, Berman N: Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab. 1997, 82 (2): 407–13. 10.1210/jc.82.2.407.
Ferrando AA, Sheffield-Moore M, Paddon-Jones D, Wolfe RR, Urban RJ: Differential anabolic effects of testosterone and amino acid feeding in older men. J Clin Endocrinol Metab. 2003, 88 (1): 358–62. 10.1210/jc.2002-021041.
Meeuwsen IB, Samson MM, Duursma SA, Verhaar HJ: Muscle strength and tibolone: a randomised, double-blind, placebo-controlled trial. Bjog. 2002, 109 (1): 77–84.
King DS, Sharp RL, Vukovich MD: Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial. Jama. 1999, 281 (21): 2020–8. 10.1001/jama.281.21.2020.
Carter WJ: Effect of anabolic hormones and insulin-like growth factor-I on muscle mass and strength in elderly persons. Clin Geriatr Med. 1995, 11 (4): 735–48.
Soe M, Jensen KL, Gluud C: [The effect of anabolic androgenic steroids on muscle strength, body weight and lean body mass in body-building men]. Ugeskr Laeger. 1989, 151 (10): 610–3.
Griggs RC, Pandya S, Florence JM: Randomized controlled trial of testosterone in myotonic dystrophy. Neurology. 1989, 39 (2 Pt 1): 219–22.
Crist DM, Stackpole PJ, Peake GT: Effects of androgenic-anabolic steroids on neuromuscular power and body composition. J Appl Physiol. 1983, 54 (2): 366–70.
Ward P: The effect of an anabolic steroid on strength and lean body mass. Med Sci Sports. 1973, 5 (4): 277–82.
Varriale P, Mirzai-tehrane M, Sedighi A: Acute myocardial infarction associated with anabolic steroids in a young HIV-infected patient. Pharmacotherapy. 1999, 19 (7): 881–4. 10.1592/phco.19.10.881.31552.
Kibble MW, Ross MB: Adverse effects of anabolic steroids in athletes. Clin Pharm. 1987, 6 (9): 686–92.
Gruber AJ, Pope HG: Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother Psychosom. 2000, 69 (1): 19–26. 10.1159/000012362.
Lamb DR: Anabolic steroids in athletics: how well do they work and how dangerous are they?. Am J Sports Med. 1984, 12 (1): 31–8. 10.1177/036354658401200105.
Salke RC, Rowland TW, Burke EJ: Left ventricular size and function in body builders using anabolic steroids. Med Sci Sports Exerc. 1985, 17 (6): 701–4. 10.1249/00005768-198512000-00014.
Broeder CE, Quindry J, Brittingham K: The Andro Project: physiological and hormonal influences of androstenedione supplementation in men 35 to 65 years old participating in a high-intensity resistance training program. Arch Intern Med. 2000, 160 (20): 3093–104. 10.1001/archinte.160.20.3093.
Ballantyne CS, Phillips SM, MacDonald JR, Tarnopolsky MA, MacDougall JD: The acute effects of androstenedione supplementation in healthy young males. Can J Appl Physiol. 2000, 25 (1): 68–78.
Brown GA, Vukovich MD, Sharp RL, Reifenrath TA, Parsons KA, King DS: Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men. J Appl Physiol. 1999, 87 (6): 2274–83.
van Gammeren D, Falk D, Antonio J: Effects of norandrostenedione and norandrostenediol in resistance-trained men. Nutrition. 2002, 18 (9): 734–7. 10.1016/S0899-9007(02)00834-1.
Brown GA, Martini ER, Roberts BS, Vukovich MD, King DS: Acute hormonal response to sublingual androstenediol intake in young men. J Appl Physiol. 2002, 92 (1): 142–6.
Van Gammeren D, Falk D, Antonio J: The effects of supplementation with 19-nor-4-androstene-3,17-dione and 19-nor-4-androstene-3,17-diol on body composition and athletic performance in previously weight-trained male athletes. Eur J Appl Physiol. 2001, 84 (5): 426–31. 10.1007/s004210100395.
Pipe A: Effects of testosterone precursor supplementation on intensive weight training. Clin J Sport Med. 2001, 11 (2): 126. 10.1097/00042752-200104000-00014.
Brown GA, Vukovich MD, Martini ER: Effects of androstenedione-herbal supplementation on serum sex hormone concentrations in 30- to 59-year-old men. Int J Vitam Nutr Res. 2001, 71 (5): 293–301. 10.1024/0300-98188.8.131.523.
Antonio J, Uelmen J, Rodriguez R, Earnest C: The effects of Tribulus terrestris on body composition and exercise performance in resistance-trained males. Int J Sport Nutr Exerc Metab. 2000, 10 (2): 208–15.
Fawcett JP, Farquhar SJ, Walker RJ, Thou T, Lowe G, Goulding A: The effect of oral vanadyl sulfate on body composition and performance in weight-training athletes. Int J Sport Nutr. 1996, 6 (4): 382–90.
Fawcett JP, Farquhar SJ, Thou T, Shand BI: Oral vanadyl sulphate does not affect blood cells, viscosity or biochemistry in humans. Pharmacol Toxicol. 1997, 80 (4): 202–6. 10.1111/j.1600-0773.1997.tb00397.x.
Kreider RB: New weight-control options. Functional Foods & Nutraceuticals. 2002, July/August: 34–42.
Hoie LH, Bruusgaard D, Thom E: Reduction of body mass and change in body composition on a very low calorie diet. Int J Obes Relat Metab Disord. 1993, 17 (1): 17–20.
Bryner RW, Ullrich IH, Sauers J: Effects of resistance vs. aerobic training combined with an 800 calorie liquid diet on lean body mass and resting metabolic rate. J Am Coll Nutr. 1999, 18 (2): 115–21.
Kern PA, Trozzolino L, Wolfe G, Purdy L: Combined use of behavior modification and very low-calorie diet in weight loss and weight maintenance. Am J Med Sci. 1994, 307 (5): 325–8. 10.1097/00000441-199405000-00002.
Baba NH, Sawaya S, Torbay N, Habbal Z, Azar S, Hashim SA: High protein vs high carbohydrate hypoenergetic diet for the treatment of obese hyperinsulinemic subjects. Int J Obes Relat Metab Disord. 1999, 23 (11): 1202–6. 10.1038/sj.ijo.0801064.
Skov AR, Toubro S, Ronn B, Holm L, Astrup A: Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J Obes Relat Metab Disord. 1999, 23 (5): 528–36. 10.1038/sj.ijo.0800867.
Toubro S, Astrup AV: [A randomized comparison of two weight-reducing diets. Calorie counting versus low-fat carbohydrate-rich ad libitum diet]. Ugeskr Laeger. 1998, 160 (6): 816–20.
Aoyama T, Fukui K, Takamatsu K, Hashimoto Y, Yamamoto T: Soy protein isolate and its hydrolysate reduce body fat of dietary obese rats and genetically obese mice (yellow KK). Nutrition. 2000, 16 (5): 349–54. 10.1016/S0899-9007(00)00230-6.
Reaven GM: Diet and Syndrome X. Curr Atheroscler Rep. 2000, 2 (6): 503–7. 10.1007/s11883-000-0050-z.
Boozer CN, Daly PA, Homel P: Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat Metab Disord. 2002, 26 (5): 593–604. 10.1038/sj.ijo.0802023.
Boozer CN, Nasser JA, Heymsfield SB, Wang V, Chen G, Solomon JL: An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. Int J Obes Relat Metab Disord. 2001, 25 (3): 316–24. 10.1038/sj.ijo.0801539.
Boozer C, Daly P, Homel P: Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obesity. 2002, 26: 593–604. 10.1038/sj.ijo.0802023.
Boozer C, Nasser J, SB H, Wang V, Chen G, Solomon J: An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. Int J Obes Relat Metab Disord. 2001, 25: 316–24. 10.1038/sj.ijo.0801539.
Molnar D, Torok K, Erhardt E, Jeges S: Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents. Int J Obes Relat Metab Disord. 2000, 24 (12): 1573–8. 10.1038/sj.ijo.0801433.
Molnar D: Effects of ephedrine and aminophylline on resting energy expenditure in obese adolescents. Int J Obes Relat Metab Disord. 1993, 17 (Suppl 1): S49–52.
Greenway FL: The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent. Obes Rev. 2001, 2 (3): 199–211. 10.1046/j.1467-789x.2001.00038.x.
Greenway FL, Raum WJ, DeLany JP: The effect of an herbal dietary supplement containing ephedrine and caffeine on oxygen consumption in humans. J Altern Complement Med. 2000, 6 (6): 553–5. 10.1089/acm.2000.6.553.
Greenway FL, Ryan DH, Bray GA, Rood JC, Tucker EW, Smith SR: Pharmaceutical cost savings of treating obesity with weight loss medications. Obes Res. 1999, 7 (6): 523–31.
Greenway F, Herber D, Raum W, Morales S: Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity. Obes Res. 1999, 7 (4): 370–8.
Bent S, Tiedt T, Odden M, Shlipak M: The relative safety of ephedra compared with other herbal products. Ann Intern Med. 2003, [http://www.acponline.org/journals/annals/ephedra.htm]
Fleming GA: The FDA, regulation, and the risk of stroke. N Engl J Med. 2000, 343 (25): 1886–7. 10.1056/NEJM200012213432510.
Raben A, Jensen ND, Marckmann P, Sandstrom B, Astrup AV: [Spontaneous weight loss in young subjects of normal weight after 11 weeks of unrestricted intake of a low-fat/high-fiber diet]. Ugeskr Laeger. 1997, 159 (10): 1448–53.
Zemel M, Thompson W, Zemel P: Dietary calcium and dairy products accelerate weight and fat-loss during energy restriction in obese adults. Clin Nutri. 2002, 75:
Zemel MB: Role of dietary calcium and dairy products in modulating adiposity. Lipids. 2003, 38 (2): 139–46. 10.1007/s11745-003-1044-6.
Zemel MB: Mechanisms of dairy modulation of adiposity. J Nutr. 2003, 133 (1): 252S–6S.
Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC: Regulation of adiposity by dietary calcium. Faseb J. 2000, 14 (9): 1132–8.
Zemel MB: Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. J Am Coll Nutr. 2002, 21 (2): 146S–51S.
Davies KM, Heaney RP, Recker RR: Calcium intake and body weight. J Clin Endocrinol Metab. 2000, 85 (12): 4635–8. 10.1210/jc.85.12.4635.
Kreider RB, Miller GW, Schenck D: Effects of phosphate loading on metabolic and myocardial responses to maximal and endurance exercise. Int J Sport Nutr. 1992, 2 (1): 20–47.
Kreider RB, Miller GW, Williams MH, Somma CT, Nasser TA: Effects of phosphate loading on oxygen uptake, ventilatory anaerobic threshold, and run performance. Med Sci Sports Exerc. 1990, 22 (2): 250–6.
Kaciuba-Uscilko H, Nazar K, Chwalbinska-Moneta J: Effect of phosphate supplementation on metabolic and neuroendocrine responses to exercise and oral glucose load in obese women during weight reduction. J Physiol Pharmacol. 1993, 44 (4): 425–40.
Nazar K, Kaciuba-Uscilko H, Szczepanik J: Phosphate supplementation prevents a decrease of triiodothyronine and increases resting metabolic rate during low energy diet. J Physiol Pharmacol. 1996, 47 (2): 373–83.
Nakagawa K, Ninomiya M, Okubo T: Tea catechin supplementation increases antioxidant capacity and prevents phospholipid hydroperoxidation in plasma of humans. J Agric Food Chem. 1999, 47 (10): 3967–73. 10.1021/jf981195l.
Dulloo AG, Seydoux J, Girardier L, Chantre P, Vandermander J: Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord. 2000, 24 (2): 252–8. 10.1038/sj.ijo.0801101.
Dulloo AG, Duret C, Rohrer D: Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr. 1999, 70 (6): 1040–5.
Stanko RT, Arch JE: Inhibition of regain in body weight and fat with addition of 3-carbon compounds to the diet with hyperenergetic refeeding after weight reduction. Int J Obes Relat Metab Disord. 1996, 20 (10): 925–30.
Stanko RT, Tietze DL, Arch JE: Body composition, energy utilization, and nitrogen metabolism with a severely restricted diet supplemented with dihydroxyacetone and pyruvate. Am J Clin Nutr. 1992, 55 (4): 771–6.
Stanko RT, Reynolds HR, Hoyson R, Janosky JE, Wolf R: Pyruvate supplementation of a low-cholesterol, low-fat diet: effects on plasma lipid concentrations and body composition in hyperlipidemic patients. Am J Clin Nutr. 1994, 59 (2): 423–7.
Kalman D, Colker CM, Wilets I, Roufs JB, Antonio J: The effects of pyruvate supplementation on body composition in overweight individuals. Nutrition. 1999, 15 (5): 337–40. 10.1016/S0899-9007(99)00034-9.
Stone MH, Sanborn K, Smith LL: Effects of in-season (5 weeks) creatine and pyruvate supplementation on anaerobic performance and body composition in American football players. Int J Sport Nutr. 1999, 9 (2): 146–65.
Shigematsu N, Asano R, Shimosaka M, Okazaki M: Effect of administration with the extract of Gymnema sylvestre R. Br leaves on lipid metabolism in rats. Biol Pharm Bull. 2001, 24 (6): 713–7. 10.1248/bpb.24.713.
Shigematsu N, Asano R, Shimosaka M, Okazaki M: Effect of long term-administration with Gymnema sylvestre R. BR on plasma and liver lipid in rats. Biol Pharm Bull. 2001, 24 (6): 643–9. 10.1248/bpb.24.643.
Gallaher DD, Gallaher CM, Mahrt GJ: A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans. J Am Coll Nutr. 2002, 21 (5): 428–33.
Gallaher CM, Munion J, Hesslink R, Wise J, Gallaher DD: Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. J Nutr. 2000, 130 (11): 2753–9.
Chiang MT, Yao HT, Chen HC: Effect of dietary chitosans with different viscosity on plasma lipids and lipid peroxidation in rats fed on a diet enriched with cholesterol. Biosci Biotechnol Biochem. 2000, 64 (5): 965–71. 10.1271/bbb.64.965.
Tai TS, Sheu WH, Lee WJ, Yao HT, Chiang MT: Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia. Diabetes Care. 2000, 23 (11): 1703–4. 10.2337/diacare.23.11.1703a.
Wuolijoki E, Hirvela T, Ylitalo P: Decrease in serum LDL cholesterol with microcrystalline chitosan. Methods Find Exp Clin Pharmacol. 1999, 21 (5): 357–61. 10.1358/mf.19184.108.40.2063477.
Guerciolini R, Radu-Radulescu L, Boldrin M, Dallas J, Moore R: Comparative evaluation of fecal fat excretion induced by orlistat and chitosan. Obes Res. 2001, 9 (6): 364–7. 10.1038/oby.2001.47.
Pittler MH, Abbot NC, Harkness EF, Ernst E: Randomized, double-blind trial of chitosan for body weight reduction. Eur J Clin Nutr. 1999, 53 (5): 379–81. 10.1038/sj.ejcn.1600733.
Ho SC, Tai ES, Eng PH, Tan CE, Fok AC: In the absence of dietary surveillance, chitosan does not reduce plasma lipids or obesity in hypercholesterolaemic obese Asian subjects. Singapore Med J. 2001, 42 (1): 006–10.
Penzak SR, Jann MW, Cold JA, Hon YY, Desai HD, Gurley BJ: Seville (sour) orange juice: synephrine content and cardiovascular effects in normotensive adults. J Clin Pharmacol. 2001, 41 (10): 1059–63. 10.1177/00912700122012652.
Moro CO, Basile G: Obesity and medicinal plants. Fitoterapia. 2000, 71 (Suppl 1): S73–82. 10.1016/S0367-326X(00)00177-5.
Cavallo E, Armellini F, Zamboni M, Vicentini R, Milani MP, Bosello O: Resting metabolic rate, body composition and thyroid hormones. Short term effects of very low calorie diet. Horm Metab Res. 1990, 22 (12): 632–5. 10.1055/s-2007-1004990.
Goglia F, Silvestri E, Lanni A: Thyroid hormones and mitochondria. Biosci Rep. 2002, 22 (1): 17–32. 10.1023/A:1016056905347.
Wilson JH, Lamberts SW: The effect of triiodothyronine on weight loss and nitrogen balance of obese patients on a very-low-calorie liquid-formula diet. Int J Obes. 1981, 5 (3): 279–82.
Rama Rao SV, Sunder GS, Reddy MR, Praharaj NK, Raju MV, Panda AK: Effect of supplementary choline on the performance of broiler breeders fed on different energy sources. Br Poult Sci. 2001, 42 (3): 362–7. 10.1080/00071660120055340.
Buchman AL, Awal M, Jenden D, Roch M, Kang SH: The effect of lecithin supplementation on plasma choline concentrations during a marathon. J Am Coll Nutr. 2000, 19 (6): 768–70.
Buchman AL, Jenden D, Roch M: Plasma free, phospholipid-bound and urinary free choline all decrease during a marathon run and may be associated with impaired performance. J Am Coll Nutr. 1999, 18 (6): 598–601.
Garcia Neto M, Pesti GM, Bakalli RI: Influence of dietary protein level on the broiler chicken's response to methionine and betaine supplements. Poult Sci. 2000, 79 (10): 1478–84.
Overland M, Rorvik KA, Skrede A: Effect of trimethylamine oxide and betaine in swine diets on growth performance, carcass characteristics, nutrient digestibility, and sensory quality of pork. J Anim Sci. 1999, 77 (8): 2143–53.
Schwab U, Torronen A, Toppinen L: Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. Am J Clin Nutr. 2002, 76 (5): 961–7.
Ammon HP, Muller AB: Forskolin: from an ayurvedic remedy to a modern agent. Planta Med. 1985, 473–7. 10.1055/s-2007-969566. 6
Ammon HP, Muller AB: Effect of forskolin on islet cyclic AMP, insulin secretion, blood glucose and intravenous glucose tolerance in rats. Naunyn Schmiedebergs Arch Pharmacol. 1984, 326 (4): 364–7. 10.1007/BF00501444.
de Souza NJ, Dohadwalla AN, Reden J: Forskolin: a labdane diterpenoid with antihypertensive, positive inotropic, platelet aggregation inhibitory, and adenylate cyclase activating properties. Med Res Rev. 1983, 3 (2): 201–19. 10.1002/med.2610030205.
Litosch I, Saito Y, Fain JN: Forskolin as an activator of cyclic AMP accumulation and secretion in blowfly salivary glands. Biochem J. 1982, 204 (1): 147–51.
Litosch I, Hudson TH, Mills I, Li SY, Fain JN: Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes. Mol Pharmacol. 1982, 22 (1): 109–15.
Seamon KB, Padgett W, Daly JW: Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci USA. 1981, 78 (6): 3363–7. 10.1073/pnas.78.6.3363.
Badmaev V, Majeed M, Conte AA, Parker JE: Diterpene forskolin (Coleus forskohlii, Benth.): A possible new compound for reduction of body weight by increasing lean body mass. 2001, Piscataway, NJ: Sabinsa Corporation
Kreider RB, Henderson S, Magu B: Effects of coleus forskohlii supplementation on body composition and markers of health in sedentary overweight females. FASEB J. 2002, LB59.
Ebeling P, Koivisto VA: Physiological importance of dehydroepiandrosterone. Lancet. 1994, 343 (8911): 1479–81. 10.1016/S0140-6736(94)92587-9.
Denti L, Pasolini G, Sanfelici L: Effects of aging on dehydroepiandrosterone sulfate in relation to fasting insulin levels and body composition assessed by bioimpedance analysis. Metabolism. 1997, 46 (7): 826–32. 10.1016/S0026-0495(97)90130-X.
De Pergola G, Zamboni M, Sciaraffia M: Body fat accumulation is possibly responsible for lower dehydroepiandrosterone circulating levels in premenopausal obese women. Int J Obes Relat Metab Disord. 1996, 20 (12): 1105–10.
Nestler JE, Barlascini CO, Clore JN, Blackard WG: Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab. 1988, 66 (1): 57–61. 10.1210/jcem-66-1-57.
Vogiatzi MG, Boeck MA, Vlachopapadopoulou E, el-Rashid R, New MI: Dehydroepiandrosterone in morbidly obese adolescents: effects on weight, body composition, lipids, and insulin resistance. Metabolism. 1996, 45 (8): 1011–5. 10.1016/S0026-0495(96)90272-3.
Kalman DS, Colker CM, Swain MA, Torina GC, Shi Q: A randomized double-blind, placebo-controlled study of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy overweight adults. Curr Thera. 2000, 61: 435–42. 10.1016/S0011-393X(00)80026-0.
MacDonald HB: Conjugated linoleic acid and disease prevention: a review of current knowledge. J Am Coll Nutr. 2000, 19 (2 Suppl): 111S–8S.
Lowery LM, Appicelli PA, PWR L: Conjugated linoleic acid enhances muscle size and strength gains in novice bodybuilders. Med Sci Sports Exerc. 1998, 30 (5): S182.
Riserus U, Berglund L, Vessby B: Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial. Int J Obes Relat Metab Disord. 2001, 25 (8): 1129–35. 10.1038/sj.ijo.0801659.
Riserus U, Arner P, Brismar K, Vessby B: Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care. 2002, 25 (9): 1516–21. 10.2337/diacare.25.9.1516.
Riserus U, Basu S, Jovinge S, Fredrikson GN, Arnlov J, Vessby B: Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation. 2002, 106 (15): 1925–9. 10.1161/01.CIR.0000033589.15413.48.
Thom E, Wadstein J, Gudmundsen O: Conjugated linoleic acid reduces body fat in healthy exercising humans. J Int Med Res. 2001, 29 (5): 392–6.
Von Loeffelholz C, Von Loeffelholz BA, Von Loeffelholz B, Jahreis G: Influence of conjugated linoleic acid (CLA) supplementation on body composition and strength in bodybuilders. Symposium: Vitamine und Zusatzstoffe; 1999: Jena (Thhr). 1999, 238–43.
Beuker F, Haak H, Schwietz H: CLA and body styling. Symposium: Vitamine und Zusatzstoffe; 1999: Jena (Thhr). 1999, 229–37.
Medina EA, Horn WF, Keim NL: Conjugated linoleic acid supplementation in humans: effects on circulating leptin concentrations and appetite. Lipids. 2000, 35 (7): 783–8. 10.1007/s11745-000-0586-y.
Jena BS, Jayaprakasha GK, Singh RP, Sakariah KK: Chemistry and biochemistry of (-)-hydroxycitric acid from Garcinia. J Agric Food Chem. 2002, 50 (1): 10–22. 10.1021/jf010753k.
Ishihara K, Oyaizu S, Onuki K, Lim K, Fushiki T: Chronic (-)-hydroxycitrate administration spares carbohydrate utilization and promotes lipid oxidation during exercise in mice. J Nutr. 2000, 130 (12): 2990–5.
Kriketos AD, Thompson HR, Greene H, Hill JO: (-)-Hydroxycitric acid does not affect energy expenditure and substrate oxidation in adult males in a post-absorptive state. Int J Obes Relat Metab Disord. 1999, 23 (8): 867–73. 10.1038/sj.ijo.0800965.
Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C: Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. Jama. 1998, 280 (18): 1596–600. 10.1001/jama.280.18.1596.
Mattes RD, Bormann L: Effects of (-)-hydroxycitric acid on appetitive variables. Physiol Behav. 2000, 71 (1–2): 87–94. 10.1016/S0031-9384(00)00321-8.
Brass EP: Supplemental carnitine and exercise. Am J Clin Nutr. 2000, 72 (2 Suppl): 618S–23S.
Villani RG, Gannon J, Self M, Rich PA: L-Carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women. Int J Sport Nutr Exerc Metab. 2000, 10 (2): 199–207.
Grases F, Melero G, Costa-Bauza A, Prieto R, March JG: Urolithiasis and phytotherapy. Int Urol Nephrol. 1994, 26 (5): 507–11. 10.1007/BF02767650.
Grases F, Llompart I, Conte A, Coll R, March JG: Glycosaminoglycans and oxalocalcic urolithiasis. Nephron. 1994, 68 (4): 449–53. 10.1159/000188306.
Dolan RL, Crosby EC, Leutkemeir MJ, Barton RG, Askew EW: The effects of diuretics on resting metabolic rate and subsequent shifts in respiratory exchange ratios. Med Sci Sports Exerc. 2001, 33: S163. 10.1097/00005768-200105001-00921.
Crosby EC, Dolan RL, Benson JE, Leutkemeir MJ, Barton RG, Askew EW: Herbal diuretic induced dehydration and resting metabolic rate. Med Sci Sports Exerc. 2001, 33: S163. 10.1097/00005768-200105001-00920.
Derave W, Op'T Eijinde B, Richter EA, Hespel P: Combined creatine and protein supplementation improves glucose tolerance and muscle glycogen accumulation in humans. Abstracts of 6th Internationl Conference on Guanidino Compounds in Biology and Medicine. 2001
Nelson AG, Arnall DA, Kokkonen J, Day , Evans J: Muscle glycogen supercompensation is enhanced by prior creatine supplementation. Med Sci Sports Exerc. 2001, 33 (7): 1096–100.
Op 't Eijnde B, Urso B, Richter EA, Greenhaff PL, Hespel P: Effect of oral creatine supplementation on human muscle GLUT4 protein content after immobilization. Diabetes. 2001, 50 (1): 18–23. 10.2337/diabetes.50.1.18.
Green AL, Hultman E, Macdonald IA, Sewell DA, Greenhaff PL: Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans. Am J Physiol. 1996, 271 (5 Pt 1): E821–6.
Nelson AG, Day R, Glickman-Weiss EL, Hegsted M, Kokkonen J, Sampson B: Creatine supplementation alters the response to a graded cycle ergometer test. Eur J Appl Physiol. 2000, 83 (1): 89–94. 10.1007/s004210000244.
Nelson AG, Day R, Glickman-Weiss EL, Hegsted M, Sampson B: Creatine supplementation raises anaerobic threshold. FASEB Journal. 1997, 11: A589.
Cade R, Conte M, Zauner C: Effects of phosphate loading on 2,3 diphosphoglycerate and maximal oxygen uptake. Med Sci Sports Exerc. 1984, 16: 263–8.
Stewart I, McNaughton L, Davies P, Tristram S: Phosphate loading and the effects of VO2max in trained cyclists. Res Quart. 1990, 61: 80–4.
McNaughton L, Backx K, Palmer G, Strange N: Effects of chronic bicarbonate ingestion on the performance of high-intensity work. Eur J Appl Physiol Occup Physiol. 1999, 80 (4): 333–6. 10.1007/s004210050600.
Applegate E: Effective nutritional ergogenic aids. Int J Sport Nutr. 1999, 9 (2): 229–39.
Kronfeld DS, Ferrante PL, Grandjean D: Optimal nutrition for athletic performance, with emphasis on fat adaptation in dogs and horses. J Nutr. 1994, 124 (12 Suppl): 2745S–53S.
Kraemer WJ, Gordon SE, Lynch JM, Pop ME, Clark KL: Effects of multibuffer supplementation on acid-base balance and 2,3-diphosphoglycerate following repetitive anaerobic exercise. Int J Sport Nutr. 1995, 5 (4): 300–14.
Matson LG, Tran ZV: Effects of sodium bicarbonate ingestion on anaerobic performance: a meta-analytic review. Int J Sport Nutr. 1993, 3 (1): 2–28.
Graham TE: Caffeine, coffee and ephedrine: impact on exercise performance and metabolism. Can J Appl Physiol. 2001, 26 (Suppl): S103–19.
Tarnopolsky MA, Atkinson SA, MacDougall JD, Sale DG, Sutton JR: Physiological responses to caffeine during endurance running in habitual caffeine users. Med Sci Sports Exerc. 1989, 21 (4): 418–24.
Armstrong LE: Caffeine, body fluid-electrolyte balance, and exercise performance. Int J Sport Nutr Exerc Metab. 2002, 12 (2): 189–206.
Graham TE: Caffeine and exercise: metabolism, endurance and performance. Sports Med. 2001, 31 (11): 785–807. 10.2165/00007256-200131110-00002.
Falk B, Burstein R, Rosenblum J, Shapiro Y, Zylber-Katz E, Bashan N: Effects of caffeine ingestion on body fluid balance and thermoregulation during exercise. Can J Physiol Pharmacol. 1990, 68 (7): 889–92.
Tarnopolsky MA: Potential use of creatine monohydrate in muscular dystrophy and nuerometabolic disorders. Abstracts of 6th Internationl Conference on Guanidino Compounds in Biology and Medicine. 2001
Wagner DR: Hyperhydrating with glycerol: implications for athletic performance. J Am Diet Assoc. 1999, 99 (2): 207–12. 10.1016/S0002-8223(99)00049-8.
Inder WJ, Swanney MP, Donald RA, Prickett TC, Hellemans J: The effect of glycerol and desmopressin on exercise performance and hydration in triathletes. Med Sci Sports Exerc. 1998, 30 (8): 1263–9. 10.1097/00005768-199808000-00013.
Montner P, Stark DM, Riedesel ML: Pre-exercise glycerol hydration improves cycling endurance time. Int J Sports Med. 1996, 17 (1): 27–33. 10.1055/s-2007-972804.
Boulay MR, Song TM, Serresse O, Theriault G, Simoneau JA, Bouchard C: Changes in plasma electrolytes and muscle substrates during short-term maximal exercise in humans. Can J Appl Physiol. 1995, 20 (1): 89–101.
Tikuisis P, Ducharme MB, Moroz D, Jacobs I: Physiological responses of exercised-fatigued individuals exposed to wet-cold conditions. J Appl Physiol. 1999, 86 (4): 1319–28.
Jimenez C, Melin B, Koulmann N, Allevard AM, Launay JC, Savourey G: Plasma volume changes during and after acute variations of body hydration level in humans. Eur J Appl Physiol Occup Physiol. 1999, 80 (1): 1–8. 10.1007/s004210050550.
Magal M, Webster MJ, Sistrunk LE, Whitehead MT, Evans RK, Boyd JC: Comparison of glycerol and water hydration regimens on tennis-related performance. Med Sci Sports Exerc. 2003, 35 (1): 150–6. 10.1097/00005768-200301000-00023.
Bell DG, McLellan TM, Sabiston CM: Effect of ingesting caffeine and ephedrine on 10-km run performance. Med Sci Sports Exerc. 2002, 34 (2): 344–9. 10.1097/00005768-200202000-00024.
Bell DG, Jacobs I, Ellerington K: Effect of caffeine and ephedrine ingestion on anaerobic exercise performance. Med Sci Sports Exerc. 2001, 33 (8): 1399–403. 10.1097/00005768-200108000-00024.
Bell DG, Jacobs I, McLellan TM, Zamecnik J: Reducing the dose of combined caffeine and ephedrine preserves the ergogenic effect. Aviat Space Environ Med. 2000, 71 (4): 415–9.
Bell DG, Jacobs I: Combined caffeine and ephedrine ingestion improves run times of Canadian Forces Warrior Test. Aviat Space Environ Med. 1999, 70 (4): 325–9.
Bell DG, Jacobs I, Zamecnik J: Effects of caffeine, ephedrine and their combination on time to exhaustion during high-intensity exercise. Eur J Appl Physiol Occup Physiol. 1998, 77 (5): 427–33. 10.1007/s004210050355.
Jeukendrup AE, Saris WH, Wagenmakers AJ: Fat metabolism during exercise: a review – part III: effects of nutritional interventions. Int J Sports Med. 1998, 19 (6): 371–9. 10.1055/s-2007-971932.
Goedecke JH, Elmer-English R, Dennis SC, Schloss I, Noakes TD, Lambert EV: Effects of medium-chain triaclyglycerol ingested with carbohydrate on metabolism and exercise performance. Int J Sport Nutr. 1999, 9 (1): 35–47.
Calabrese C, Myer S, Munson S, Turet P, Birdsall TC: A cross-over study of the effect of a single oral feeding of medium chain triglyceride oil vs. canola oil on post-ingestion plasma triglyceride levels in healthy men. Altern Med Rev. 1999, 4 (1): 23–8.
Angus DJ, Hargreaves M, Dancey J, Febbraio MA: Effect of carbohydrate or carbohydrate plus medium-chain triglyceride ingestion on cycling time trial performance. J Appl Physiol. 2000, 88 (1): 113–9.
Jeukendrup AE, Thielen JJ, Wagenmakers AJ, Brouns F, Saris WH: Effect of medium-chain triacylglycerol and carbohydrate ingestion during exercise on substrate utilization and subsequent cycling performance. Am J Clin Nutr. 1998, 67 (3): 397–404.
Van Zyl CG, Lambert EV, Hawley JA, Noakes TD, Dennis SC: Effects of medium-chain triglyceride ingestion on fuel metabolism and cycling performance. J Appl Physiol. 1996, 80 (6): 2217–25.
Tullson PC, Terjung RL: Adenine nucleotide synthesis in exercising and endurance-trained skeletal muscle. Am J Physiol. 1991, 261 (2 Pt 1): C342–7.
Gross M, Kormann B, Zollner N: Ribose administration during exercise: effects on substrates and products of energy metabolism in healthy subjects and a patient with myoadenylate deaminase deficiency. Klin Wochenschr. 1991, 69 (4): 151–5. 10.1007/BF01665856.
Wagner DR, Gresser U, Kamilli I, Gross M, Zollner N: Effects of oral ribose on muscle metabolism during bicycle ergometer in patients with AMP-deaminase-deficiency. Adv Exp Med Biol. 1991, 383–5.
Pliml W, von Arnim T, Stablein A, Hofmann H, Zimmer HG, Erdmann E: Effects of ribose on exercise-induced ischaemia in stable coronary artery disease. Lancet. 1992, 340 (8818): 507–10. 10.1016/0140-6736(92)91709-H.
Pauly DF, Pepine CJ: D-Ribose as a supplement for cardiac energy metabolism. J Cardiovasc Pharmacol Ther. 2000, 5 (4): 249–58. 10.1054/JCPT.2000.18011.
Op 't Eijnde B, Van Leemputte M, Brouns F: No effects of oral ribose supplementation on repeated maximal exercise and de novo ATP resynthesis. J Appl Physiol. 2001, 91 (5): 2275–81.
Berardi JM, Ziegenfuss TN: Effects of ribose supplementation on repeated sprint performance in men. J Strength Cond Res. 2003, 17 (1): 47–52. 10.1519/1533-4287(2003)017<0047:EORSOR>2.0.CO;2.
Kreider RB, Melton C, Greenwood M: Effects of oral d-ribose supplementation on anaerobic capacity and selected metabolic markers in healthy males. Int J Sport Nutr Exerc Metab. 2003, 13 (1): 87–96.
Hargreaves M, McKenna MJ, Jenkins DG: Muscle metabolites and performance during high-intensity, intermittent exercise. J Appl Physiol. 1998, 84 (5): 1687–91.
Starling RD, Trappe TA, Short KR: Effect of inosine supplementation on aerobic and anaerobic cycling performance. Med Sci Sports Exerc. 1996, 28 (9): 1193–8.
Williams MH, Kreider RB, Hunter DW: Effect of inosine supplementation on 3-mile treadmill run performance and VO2 peak. Med Sci Sports Exerc. 1990, 22 (4): 517–22.
McNaughton L, Dalton B, Tarr J: Inosine supplementation has no effect on aerobic or anaerobic cycling performance. Int J Sport Nutr. 1999, 9 (4): 333–44.
Braham R, Dawson B, Goodman C: The effect of glucosamine supplementation on people experiencing regular knee pain. Br J Sports Med. 2003, 37 (1): 45–9. 10.1136/bjsm.37.1.45. discussion 9
Vad V, Hong HM, Zazzali M, Agi N, Basrai D: Exercise recommendations in athletes with early osteoarthritis of the knee. Sports Med. 2002, 32 (11): 729–39. 10.2165/00007256-200232110-00004.
Nieman DC: Exercise immunology: nutritional countermeasures. Can J Appl Physiol. 2001, 26 (Suppl): S45–55.
Gleeson M, Lancaster GI, Bishop NC: Nutritional strategies to minimise exercise-induced immunosuppression in athletes. Can J Appl Physiol. 2001, 26 (Suppl): S23–35.
Gleeson M, Bishop NC: Elite athlete immunology: importance of nutrition. Int J Sports Med. 2000, 21 (Suppl 1): S44–50. 10.1055/s-2000-1451.
Lowery L, Berardi JM, Ziegenfuss T: Antioxidants. Sports Supplements. Edited by: Antonio J, Stout J. 2001, Baltimore, MD: Lippincott, Williams & Wilkins, 260–78.
Gomez AL, Volek JS, Ratamess NA: Creatine supplementation enhances body composition during short-term reisstance training overreaching. Journal of Strength and Conditioning Research. 2000, 14 (3):
French DN, Volek JS, Ratamess NA: The effects of creatine supplementation on resting serum hormonal concentrations during short-term resistance training overreaching. Med Sci Sports & Exerc. 2001, 33 (5): S203. 10.1097/00005768-200105001-01142.
Volek JS, Kraemer WJ, Rubin MR, Gomez AL, Ratamess NA, Gaynor P: L-Carnitine L-tartrate supplementation favorably affects markers of recovery from exercise stress. Am J Physiol Endocrinol Metab. 2002, 282 (2): E474–82.
Mero A: Leucine supplementation and intensive training. Sports Med. 1999, 27 (6): 347–58. 10.2165/00007256-199927060-00001.
Harris RC, Soderlund K, Hultman E: Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci (Colch). 1992, 83 (3): 367–74.
Williams MH: Vitamin supplementation and athletic performance. Int J Vitam Nutr Res Suppl. 1989, 30: 163–91.
Reid IR: Therapy of osteoporosis: calcium, vitamin D, and exercise. Am J Med Sci. 1996, 312 (6): 278–86. 10.1097/00000441-199612000-00006.
Goldfarb AH: Antioxidants: role of supplementation to prevent exercise-induced oxidative stress. Med Sci Sports Exerc. 1993, 25 (2): 232–6.
Goldfarb AH: Nutritional antioxidants as therapeutic and preventive modalities in exercise-induced muscle damage. Can J Appl Physiol. 1999, 24 (3): 249–66.
Appell HJ, Duarte JA, Soares JM: Supplementation of vitamin E may attenuate skeletal muscle immobilization atrophy. Int J Sports Med. 1997, 18 (3): 157–60. 10.1055/s-2007-972612.
Tiidus PM, Houston ME: Vitamin E status and response to exercise training. Sports Med. 1995, 20 (1): 12–23. 10.2165/00007256-199520010-00002.
Craciun AM, Wolf J, Knapen MH, Brouns F, Vermeer C: Improved bone metabolism in female elite athletes after vitamin K supplementation. Int J Sports Med. 1998, 19 (7): 479–84. 10.1055/s-2007-971948.
Fogelholm M, Ruokonen I, Laakso JT, Vuorimaa T, Himberg JJ: Lack of association between indices of vitamin B1, B2, and B6 status and exercise-induced blood lactate in young adults. Int J Sport Nutr. 1993, 3 (2): 165–76.
Garg R, Malinow M, Pettinger M, Upson B, Hunninghake D: Niacin treatment increases plasma homocyst(e)ine levels. Am Heart J. 1999, 138 (6 Pt 1): 1082–7. 10.1016/S0002-8703(99)70073-6.
Alaswad K, O'Keefe JH, Moe RM: Combination drug therapy for dyslipidemia. Curr Atheroscler Rep. 1999, 1 (1): 44–9. 10.1007/s11883-999-0049-z.
Murray R, Bartoli WP, Eddy DE, Horn MK: Physiological and performance responses to nicotinic-acid ingestion during exercise. Med Sci Sports Exerc. 1995, 27 (7): 1057–62. 10.1249/00005768-199507000-00015.
Bonke D: Influence of vitamin B1, B6, and B12 on the control of fine motoric movements. Bibl Nutr Dieta. 1986, 104–9. 38
Bonke D, Nickel B: Improvement of fine motoric movement control by elevated dosages of vitamin B1, B6, and B12 in target shooting. Int J Vitam Nutr Res Suppl. 1989, 30: 198–204.
Van Dyke DC, Stumbo PJ, Mary JB, Niebyl JR: Folic acid and prevention of birth defects. Dev Med Child Neurol. 2002, 44 (6): 426–9. 10.1017/S0012162201002316.
Mattson MP, Kruman II, Duan W: Folic acid and homocysteine in age-related disease. Ageing Res Rev. 2002, 1 (1): 95–111. 10.1016/S0047-6374(01)00365-7.
Weston PM, King RF, Goode AW, Williams NS: Diet-induced thermogenesis in patients with gastrointestinal cancer cachexia. Clin Sci (Lond). 1989, 77 (2): 133–8.
Webster MJ: Physiological and performance responses to supplementation with thiamin and pantothenic acid derivatives. Eur J Appl Physiol Occup Physiol. 1998, 77 (6): 486–91. 10.1007/s004210050364.
van der Beek EJ, Lowik MR, Hulshof KF, Kistemaker C: Combinations of low thiamin, riboflavin, vitamin B6 and vitamin C intake among Dutch adults. (Dutch Nutrition Surveillance System). J Am Coll Nutr. 1994, 13 (4): 383–91.
van der Beek EJ: Vitamin supplementation and physical exercise performance. J Sports Sci. 1991, 9 (Spec No): 77–90.
Pedersen BK, Bruunsgaard H, Jensen M, Krzywkowski K, Ostrowski K: Exercise and immune function: effect of ageing and nutrition. Proc Nutr Soc. 1999, 58 (3): 733–42.
Petersen EW, Ostrowski K, Ibfelt T: Effect of vitamin supplementation on cytokine response and on muscle damage after strenuous exercise. Am J Physiol Cell Physiol. 2001, 280 (6): C1570–5.